retatrutide is a glp 3 GLP-3 RT (LY3437943) Peptide GLP-3: RT - Simon's Compounding
Description
60 tablets - Shipped Once
Navigate the complexities of Ozempic lawsuits with RTRLAW
The disparity in coverage between the anti-diabetic and anti-obesity GLP-1s shows how payer behavior is driven by the perceived medical necessity of products by their intended use, not by the molecule itself
Schematic illustration below was taken from He et al
Ozempic isnt FDA-approved for PCOS, but some patients may still qualify for coverage
Blue Cross Blue Shield generally covers Trulicity, but coverage varies by plan, and you may need prior authorization
